Peter ten Dijke

Papers

Total Citations

H-Index

About

Peter ten Dijke is a pioneering cell and molecular biologist whose research has fundamentally shaped our understanding of transforming growth factor-β (TGF-β) signaling and its role in cancer, fibrosis, and stem cell biology. He is best known for his landmark discovery of the Smad proteins—the intracellular mediators of TGF-β family signals—which revolutionized the field and opened new avenues for therapeutic targeting. With over 50,000 citations across his career, his work has had a profound and lasting impact, particularly his elucidation of how TGF-β switches from a tumor suppressor to a metastasis promoter in advanced cancers. More recently, ten Dijke has advanced translational cancer research by developing automated microinjection platforms for zebrafish xenograft models, enabling high-throughput, personalized drug screening. His contributions have earned him numerous accolades, including membership in the Royal Netherlands Academy of Arts and Sciences. For students and researchers, ten Dijke’s career exemplifies how fundamental mechanistic insights can drive both biological discovery and clinical innovation.